vTv Therapeutics (VTVT) Interest Coverage Ratio (2014 - 2025)

vTv Therapeutics has disclosed Interest Coverage Ratio across 11 years of filings, most recently posting 7885.0 for Q4 2025.

• Interest Coverage Ratio for Q4 2025 came in at 7885.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 507.0 (changed N/A YoY), and the FY2025 annual result was 5468.0, changed N/A from the prior year.
• Interest Coverage Ratio came in at 7885.0 for Q4 2025 at vTv Therapeutics, down from 2139.8 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 267.17 in Q3 2021 to a low of 7885.0 in Q4 2025.
• The 4-year median for Interest Coverage Ratio is 1596.75 (2021), against an average of 2640.72.
• Across the five-year window, Interest Coverage Ratio tumbled 6878.72% in 2021 and soared 42.9% in 2022, its largest moves.
• vTv Therapeutics' Interest Coverage Ratio stood at 1851.5 in 2021, then jumped by 42.9% to 1057.17 in 2022, then surged by 36.39% to 672.43 in 2023, then tumbled by 1072.62% to 7885.0 in 2025.
• The last three Interest Coverage Ratio figures came in at 7885.0 (Q4 2025), 2139.8 (Q3 2025), and 672.43 (Q4 2023), per Business Quant data.